Company: LIMN
Filing Date: 2025-08-13
Form Type: 424B3
Source: 0001410578-25-001746
Chunk: 309

Company: Liminatus Pharma, Inc.
Filing Date: 2025-08-13
Form: 424B3
Chunk 309
---
 for income taxes                                                                     | ​ | ​                                | -2,885,458 | ​ | ​ | -1,192,231 |
| Provision for income taxes                                                                                 | ​ | ​                                |    -18,841 | ​ | ​ |    -33,987 |
| Net loss                                                                                                   | ​ | $                                | -2,904,299 | ​ | $ | -1,226,218 |
| ​                                                                                                          | ​ |                                  |          ​ | ​ |   |          ​ |
| Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption | ​ |                                  |  7,191,610 | ​ | ​ |  3,040,753 |
| Basic and diluted net loss per share, Class A common stock subject to possible redemption                  | ​ | $                                |      -0.40 | ​ | $ |      -0.15 |
| Basic and diluted weighted average shares outstanding, Class B common stock                                | ​ |                                  |          — | ​ |   |  4,971,781 |
| Basic and diluted net loss per share, Class B common stock                                                 | ​ | $                                |          — | ​ | $ |      -0.15 |

The accompanying notes are an integral part of these financial statements.

F-79

IRIS ACQUISITION CORP STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT FOR THE YEARS ENDED DECEMBER 31, 2024 AND 2023

| ​                                                                     
 ​                                                                     
 ​                                                                     
 ​                                                                     | ​ 
 ​ 
 ​ |            ​ 
      Class A 
 Common Stock 
       Shares | ​ | ​      
 Amount |   ​ | ​ 
 ​ 
 ​ |            ​ 
      Class B 
 Common Stock 
       Shares | ​ | ​      
 Amount |    ​ | ​ 
 ​ 
 ​ | ​            
 Extension    
 deposits due 
 from Sponsor |        ​ | ​ 
 ​ 
 ​ | ​          
 Additional 
 Paid-in    
 Capital    |        ​ | ​ 
 ​ 
 ​ | ​           
 ​           
 Accumulated 
 Deficit     |           ​ 
           ​ | ​ 
 ​ 
 ​ | ​             
 Total         
 Stockholders’ 
 Deficit       |           ​ |
|:----------------------------------------------------------------------|:--|-------------:|:--|:-------|----:|:--|-------------:|:--|:-------|-----:|:--|:-------------|---------:|:--|:-----------|---------: